Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127543002 | 12754300 | 2 | F | 20160815 | 20160909 | 20160916 | 20160922 | EXP | GB-MHRA-ADR 23610171 | GB-ALVOGEN-2016-ALVOGEN-028473 | ALVOGEN | 82.00 | YR | E | M | Y | 63.50000 | KG | 20160922 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127543002 | 12754300 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | D | 62800 | 300 | MG | CAPSULE, HARD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127543002 | 12754300 | 1 | Infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127543002 | 12754300 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127543002 | 12754300 | Fatigue | |
127543002 | 12754300 | Feeling abnormal | |
127543002 | 12754300 | Rash pruritic | |
127543002 | 12754300 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127543002 | 12754300 | 1 | 20160801 | 20160808 | 0 |